Should antipsychotic medication be continued during an active catatonic episode in a patient with schizophrenia?

Discontinue Antipsychotics During Active Catatonia in Schizophrenia

You should discontinue or avoid antipsychotics during an active catatonic episode in schizophrenia and treat the catatonia first with benzodiazepines and/or ECT. Once catatonia resolves, antipsychotics can be cautiously reintroduced if needed for psychotic symptoms.

The Evidence Against Continuing Antipsychotics

The most recent and highest-quality evidence demonstrates that antipsychotics worsen outcomes during active catatonia, even in patients with schizophrenia:

• A 2026 retrospective study of 164 inpatients with catatonia and psychosis found that patients treated WITHOUT antipsychotics had significantly better outcomes 1. Those receiving only benzodiazepines and/or ECT showed greater improvement in both catatonic symptoms (Bush-Francis scores, p<0.0001) and psychotic symptoms (PANSS positive scores, p<0.0001) compared to those who received antipsychotics. Critically, patients who served as their own controls across multiple hospitalizations consistently had worse outcomes when antipsychotics were added.

• A 2026 cohort study of 205 patients found antipsychotics showed a biphasic effect: potential short-term benefit within 60 days (HR 0.36) but increased risk of recurrence thereafter (HR 2.14) 2. In contrast, benzodiazepines provided sustained protection against recurrence (HR 0.50, p=0.03).

• A 2025 systematic review of 175 antipsychotic trials in catatonia found only 60% beneficial outcomes overall, with 10.9% frankly harmful 3. Haloperidol was mostly detrimental, and even "safer" second-generation agents like olanzapine showed mixed results.

Treatment Algorithm for Catatonia in Schizophrenia

Step 1: Recognize and Diagnose Catatonia

• Use the Bush-Francis Catatonia Rating Scale to confirm diagnosis
• Document specific catatonic signs (stupor, rigidity, mutism, posturing, excitement, etc.)
• Check for autonomic instability suggesting malignant catatonia (hyperthermia, tachycardia, elevated CPK)

Step 2: Immediately Stop or Avoid Antipsychotics

• Discontinue current antipsychotics if the patient is already taking them—they may have precipitated or worsened the catatonia 4
• Do not initiate antipsychotics during active catatonia, even for prominent psychotic symptoms
• The psychotic symptoms will often improve when catatonia is treated 1

Step 3: First-Line Treatment with Benzodiazepines

• Lorazepam is the gold standard: Start with 1-2 mg IV/IM or PO, can repeat every 4-6 hours 5
• Perform a lorazepam challenge test: improvement within 1-2 hours supports the diagnosis
• Titrate up to 6-16 mg/day in divided doses as needed 5
• Alternative: diazepam or zolpidem if lorazepam unavailable 5
• Continue benzodiazepines until catatonia fully resolves 4

Step 4: ECT for Refractory Cases or Malignant Catatonia

• If no response to benzodiazepines after 3-5 days, proceed to ECT 6
• ECT is superior to antipsychotics for catatonia: one RCT showed significantly greater improvement with ECT versus risperidone at 3 weeks 6
• For malignant catatonia with autonomic instability, consider ECT earlier 5, 4
• Note: Dantrolene is often ineffective despite its use in NMS 4

Step 5: Reintroducing Antipsychotics After Catatonia Resolves

Once catatonia has completely resolved (Bush-Francis score normalized), if ongoing psychotic symptoms require treatment:

• Wait until catatonia is fully resolved before restarting antipsychotics
• Consider clozapine or quetiapine as potentially safer options if antipsychotic is necessary 5, 7
• A 2013 case series found quetiapine was used successfully in 61.5% of schizophrenia patients after recovery from catatonic stupor 7
• Avoid typical antipsychotics like haloperidol, which have the worst outcomes 3
• Restart at low doses with close monitoring for re-emergence of catatonic signs

Critical Pitfalls to Avoid

Do not confuse catatonia with treatment-resistant psychosis. The major guidelines on schizophrenia treatment 8, 9 appropriately recommend continuing antipsychotics for schizophrenia and escalating to clozapine for treatment resistance. However, these guidelines do not specifically address the management of acute catatonic episodes, where the treatment paradigm fundamentally changes. Catatonia is not a subtype of schizophrenia requiring antipsychotic escalation—it is a distinct neuropsychiatric syndrome requiring its own treatment approach 4.

Do not mistake catatonia for neuroleptic malignant syndrome (NMS). While NMS and malignant catatonia may exist on a spectrum and share features (rigidity, fever, elevated CPK, autonomic instability), both respond to benzodiazepines and ECT, not to continued antipsychotics 4. If you suspect either condition, stop antipsychotics immediately.

Do not assume second-generation antipsychotics are safe in active catatonia. While some case reports suggest clozapine or quetiapine may be helpful, the 2025 systematic review found non-beneficial outcomes with all second-generation antipsychotics in varying proportions 3. Even olanzapine, widely used, showed mixed results.

Maintenance Considerations

For long-term prevention after catatonia resolves:

• Benzodiazepines provide sustained protection against recurrence and may be continued long-term 2
• Some evidence supports lithium for periodic catatonia to prevent recurrent episodes 5
• If antipsychotics are reintroduced, maintain the lowest effective dose and monitor closely for re-emergence of catatonic signs

The evidence consistently shows that treating catatonia as a distinct entity—with benzodiazepines and ECT rather than antipsychotics—leads to better outcomes for both catatonic and psychotic symptoms, even in patients with underlying schizophrenia 1.